Surrey researchers Sign in
A Phase I Clinical Trial with a Novel gp41 HIV Vaccine (EN41-FPA2) in Healthy Female Volunteers: A Mucosal Prime and Intramuscular Boost Regimen
Conference presentation   Peer reviewed

A Phase I Clinical Trial with a Novel gp41 HIV Vaccine (EN41-FPA2) in Healthy Female Volunteers: A Mucosal Prime and Intramuscular Boost Regimen

AV Cope, C Moog, RJ Shattock, MM Chawda, J Czyzewska-Khan, P Kat, S Venables, C Yan, M Williams, K Cobb, …
AIDS RESEARCH AND HUMAN RETROVIRUSES, Vol.30, pp.A187-A188
Symposium on HIV Research for Prevention (HIV R4P) (Cape Town, SOUTH AFRICA, 28/10/2014 - 31/10/2014)
01/10/2014

Abstract

Science & Technology Life Sciences & Biomedicine Immunology Infectious Diseases Virology
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344774402113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

39 Record Views

Details

Usage Policy